Cash Position -- Cash and equivalents as of December 31, 2025, plus $20.2 million initial proceeds from a January 2026 PIPE and potential further $20.2 million upon milestone, are expected to fund ...

Discover how CRISPR genome editing is revolutionizing medicine. Learn the science of Cas9, current clinical trials, and the future of gene editing.

The following is the full transcript of the interview with International Atomic Energy Agency Director-General Rafael Grossi, ...

My initial comments will briefly highlight our fourth quarter and full-year 2025 results, along with the steps we are taking ...

Good afternoon, and welcome to Red Cat's Fourth Quarter and Full Year 2025 Earnings Call. Joining us are Red Cat's CEO, Jeff Thompson; COO, Chris Ericson; and CFO, Christian Morrison. Please note that ...

When you know a webinar is happening six weeks from now, you can build everything around it in advance rather than scrambling ...